|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
110 a.a.
|
 |
|
|
|
|
|
|
|
111 a.a.
|
 |
|
|
|
|
|
|
|
182 a.a.
|
 |
|
|
|
|
|
|
|
189 a.a.
|
 |
|
|
|
|
|
|
|
12 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of mouse tcr 172.10 complexed with mhc class ii i-au molecule at 2.4 a
|
|
Structure:
|
 |
T-cell receptor alpha-chain. Chain: a, e. Fragment: v2.3-j39-c. Engineered: yes. Mouse tcrvbeta 172.10, extracellular variable domain. Chain: b, f. Engineered: yes. Mutation: yes. H-2 class ii histocompatibility antigen, a-u alpha chain.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Gene: h2-aa. Expressed in: drosophila melanogaster. Expression_system_taxid: 7227. Expression_system_cell_line: s2.
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
2.42Å
|
R-factor:
|
0.232
|
R-free:
|
0.274
|
|
|
Authors:
|
 |
J.Maynard,K.Petersson,D.H.Wilson,E.J.Adams,S.E.Blondelle, M.J.Boulanger,D.B.Wilson,K.C.Garcia
|
Key ref:
|
 |
J.Maynard
et al.
(2005).
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity.
Immunity,
22,
81-92.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Jul-04
|
Release date:
|
17-May-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q5R1B3
(Q5R1B3_MOUSE) -
TRAV14-3 (Fragment) from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
120 a.a.
110 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P04213
(TVB5_MOUSE) -
T-cell receptor beta chain V region C5 (Fragment) from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
122 a.a.
111 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P14438
(HA2U_MOUSE) -
H-2 class II histocompatibility antigen, A-U alpha chain (Fragment) from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
227 a.a.
182 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Immunity
22:81-92
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity.
|
|
J.Maynard,
K.Petersson,
D.H.Wilson,
E.J.Adams,
S.E.Blondelle,
M.J.Boulanger,
D.B.Wilson,
K.C.Garcia.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
T cell receptor crossreactivity with different peptide ligands and biased
recognition of MHC are coupled features of antigen recognition that are
necessary for the T cell's diverse functional repertoire. In the crystal
structure between an autoreactive, EAE T cell clone 172.10 and myelin basic
protein (1-11) presented by class II MHC I-Au, recognition of the MHC is
dominated by the Vbeta domain of the TCR, which interacts with the MHC alpha
chain in a manner suggestive of a germline-encoded TCR/MHC "anchor
point." Strikingly, there are few specific contacts between the TCR CDR3
loops and the MBP peptide. We also find that over 1,000,000 different peptides
derived from combinatorial libraries can activate 172.10, yet the TCR strongly
prefers the native MBP contact residues. We suggest that while TCR scanning of
pMHC may be degenerate due to the TCR germline bias for MHC, recognition of
structurally distinct agonist peptides is not indicative of TCR promiscuity, but
rather highly specific alternative solutions to TCR engagement.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Structure of TCR 172.10 in Complex with
I-A^u/MBP1-11(A) Ribbon representation of the complex including
172.10Vα (red), 172.10Vβ (blue), I-A^u (green), and MBP
residues 1–8 (yellow). The CDR loops from 172.10 are colored
as follows: CDR1α (magenta), CDR2α (pink), CDR3α (red),
CDR1β (maroon), CDR2β (cyan), and CDR3β (blue).(B) Side view
(turned 90° from [A]) of the complex. MBP peptide is shown
as a transparent molecular surface (yellow) with ball-and-stick
representations of amino acids inside, including the leader
peptide (gray). The β1 helix from I-A^u is in the front, and
the α1 helix is behind the peptide.(C) 172.10 footprint showing
docking orientation on I-A^u/MBP1-11. Peptide-MHC is shown as a
green surface (peptide in yellow, leader residues in gray), and
the 172.10 CDR loops are drawn as tubes and labeled. This and
all subsequent figures were produced with PyMol (Delano, 2002).
|
 |
Figure 2.
Figure 2. 172.10 Vα and Vβ Interactions with β1 and α1
Helices of I-A^u(A) Overview of the interface between 172.10 Vα
(red) and Vβ (blue) and I-A^u (green)/MBP-peptide (yellow).(B)
Contact interface between the 172.10 Vα and the I-Au β1 helix.
All contacts are van der Waals.(C) Contact interface between the
172.10 Vβ and the I-Au α1 helix showing both hydrogen bonds
and van der Waals interactions. Labeled residues are those
involved in the hydrogen-bonding network.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Immunity
(2005,
22,
81-92)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Sewell
(2012).
Why must T cells be cross-reactive?
|
| |
Nat Rev Immunol,
12,
669-677.
|
 |
|
|
|
|
 |
D.K.Sethi,
D.A.Schubert,
A.K.Anders,
A.Heroux,
D.A.Bonsor,
C.P.Thomas,
E.J.Sundberg,
J.Pyrdol,
and
K.W.Wucherpfennig
(2011).
A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC.
|
| |
J Exp Med,
208,
91.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.W.Wucherpfennig,
and
D.Sethi
(2011).
T cell receptor recognition of self and foreign antigens in the induction of autoimmunity.
|
| |
Semin Immunol,
23,
84-91.
|
 |
|
|
|
|
 |
Y.Yin,
Y.Li,
M.C.Kerzic,
R.Martin,
and
R.A.Mariuzza
(2011).
Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection.
|
| |
EMBO J,
30,
1137-1148.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.W.Michels,
and
M.Nakayama
(2010).
The anti-insulin trimolecular complex in type 1 diabetes.
|
| |
Curr Opin Endocrinol Diabetes Obes,
17,
329-334.
|
 |
|
|
|
|
 |
B.D.Stadinski,
T.Delong,
N.Reisdorph,
R.Reisdorph,
R.L.Powell,
M.Armstrong,
J.D.Piganelli,
G.Barbour,
B.Bradley,
F.Crawford,
P.Marrack,
S.K.Mahata,
J.W.Kappler,
and
K.Haskins
(2010).
Chromogranin A is an autoantigen in type 1 diabetes.
|
| |
Nat Immunol,
11,
225-231.
|
 |
|
|
|
|
 |
T.Burster,
and
B.O.Boehm
(2010).
Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitus.
|
| |
Diabetes Metab Res Rev,
26,
227-238.
|
 |
|
|
|
|
 |
Y.Fujii,
T.Matsutani,
K.Kitaura,
S.Suzuki,
T.Itoh,
T.Takasaki,
R.Suzuki,
and
I.Kurane
(2010).
Comprehensive analysis and characterization of the TCR alpha chain sequences in the common marmoset.
|
| |
Immunogenetics,
62,
383-395.
|
 |
|
|
|
|
 |
A.Udyavar,
R.Alli,
P.Nguyen,
L.Baker,
and
T.L.Geiger
(2009).
Subtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity.
|
| |
J Immunol,
182,
4439-4447.
|
 |
|
|
|
|
 |
D.M.Kranz
(2009).
Two mechanisms that account for major histocompatibility complex restriction of T cells.
|
| |
F1000 Biol Rep,
1,
0.
|
 |
|
|
|
|
 |
J.A.Maynard,
N.C.Lindquist,
J.N.Sutherland,
A.Lesuffleur,
A.E.Warrington,
M.Rodriguez,
and
S.H.Oh
(2009).
Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins.
|
| |
Biotechnol J,
4,
1542-1558.
|
 |
|
|
|
|
 |
J.P.Scott-Browne,
J.White,
J.W.Kappler,
L.Gapin,
and
P.Marrack
(2009).
Germline-encoded amino acids in the alphabeta T-cell receptor control thymic selection.
|
| |
Nature,
458,
1043-1046.
|
 |
|
|
|
|
 |
K.Rubtsova,
J.P.Scott-Browne,
F.Crawford,
S.Dai,
P.Marrack,
and
J.W.Kappler
(2009).
Many different Vbeta CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions.
|
| |
Proc Natl Acad Sci U S A,
106,
7951-7956.
|
 |
|
|
|
|
 |
K.W.Wucherpfennig,
M.J.Call,
L.Deng,
and
R.Mariuzza
(2009).
Structural alterations in peptide-MHC recognition by self-reactive T cell receptors.
|
| |
Curr Opin Immunol,
21,
590-595.
|
 |
|
|
|
|
 |
M.Harkiolaki,
S.L.Holmes,
P.Svendsen,
J.W.Gregersen,
L.T.Jensen,
R.McMahon,
M.A.Friese,
G.van Boxel,
R.Etzensperger,
J.S.Tzartos,
K.Kranc,
S.Sainsbury,
K.Harlos,
E.D.Mellins,
J.Palace,
M.M.Esiri,
P.A.van der Merwe,
E.Y.Jones,
and
L.Fugger
(2009).
T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.
|
| |
Immunity,
30,
348-357.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.McBeth,
A.Seamons,
J.C.Pizarro,
S.J.Fleishman,
D.Baker,
T.Kortemme,
J.M.Goverman,
and
R.K.Strong
(2008).
A new twist in TCR diversity revealed by a forbidden alphabeta TCR.
|
| |
J Mol Biol,
375,
1306-1319.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.I.Godfrey,
J.Rossjohn,
and
J.McCluskey
(2008).
The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
|
| |
Immunity,
28,
304-314.
|
 |
|
|
|
|
 |
E.J.Adams,
P.Strop,
S.Shin,
Y.H.Chien,
and
K.C.Garcia
(2008).
An autonomous CDR3delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gammadelta T cells.
|
| |
Nat Immunol,
9,
777-784.
|
 |
|
|
|
|
 |
E.J.Collins,
and
D.S.Riddle
(2008).
TCR-MHC docking orientation: natural selection, or thymic selection?
|
| |
Immunol Res,
41,
267-294.
|
 |
|
|
|
|
 |
E.S.Huseby,
J.W.Kappler,
and
P.Marrack
(2008).
Thymic selection stifles TCR reactivity with the main chain structure of MHC and forces interactions with the peptide side chains.
|
| |
Mol Immunol,
45,
599-606.
|
 |
|
|
|
|
 |
L.G.Petrich de Marquesini,
A.K.Moustakas,
I.J.Thomas,
L.Wen,
G.K.Papadopoulos,
and
F.S.Wong
(2008).
Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands.
|
| |
Eur J Immunol,
38,
240-249.
|
 |
|
|
|
|
 |
L.K.Ely,
S.R.Burrows,
A.W.Purcell,
J.Rossjohn,
and
J.McCluskey
(2008).
T-cells behaving badly: structural insights into alloreactivity and autoimmunity.
|
| |
Curr Opin Immunol,
20,
575-580.
|
 |
|
|
|
|
 |
L.Li,
B.Wang,
J.A.Frelinger,
and
R.Tisch
(2008).
T-cell promiscuity in autoimmune diabetes.
|
| |
Diabetes,
57,
2099-2106.
|
 |
|
|
|
|
 |
M.Cohn
(2008).
What does the T-cell receptor recognize when it docks on an MHC-encoded restricting element?
|
| |
Mol Immunol,
45,
3264-3267.
|
 |
|
|
|
|
 |
P.Marrack,
J.P.Scott-Browne,
S.Dai,
L.Gapin,
and
J.W.Kappler
(2008).
Evolutionarily conserved amino acids that control TCR-MHC interaction.
|
| |
Annu Rev Immunol,
26,
171-203.
|
 |
|
|
|
|
 |
P.Marrack,
K.Rubtsova,
J.Scott-Browne,
and
J.W.Kappler
(2008).
T cell receptor specificity for major histocompatibility complex proteins.
|
| |
Curr Opin Immunol,
20,
203-207.
|
 |
|
|
|
|
 |
R.Etzensperger,
R.M.McMahon,
E.Y.Jones,
and
L.Fugger
(2008).
Dissection of the multiple sclerosis associated DR2 haplotype.
|
| |
J Autoimmun,
31,
201-207.
|
 |
|
|
|
|
 |
S.Dai,
E.S.Huseby,
K.Rubtsova,
J.Scott-Browne,
F.Crawford,
W.A.Macdonald,
P.Marrack,
and
J.W.Kappler
(2008).
Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules.
|
| |
Immunity,
28,
324-334.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Gras,
L.Kjer-Nielsen,
S.R.Burrows,
J.McCluskey,
and
J.Rossjohn
(2008).
T-cell receptor bias and immunity.
|
| |
Curr Opin Immunol,
20,
119-125.
|
 |
|
|
|
|
 |
X.Zhang,
Y.Tang,
D.Sujkowska,
J.Wang,
V.Ramgolam,
M.Sospedra,
J.Adams,
R.Martin,
C.Pinilla,
and
S.Markovic-Plese
(2008).
Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
|
| |
Eur J Immunol,
38,
1297-1309.
|
 |
|
|
|
|
 |
Z.Kato,
J.N.Stern,
H.K.Nakamura,
K.Kuwata,
N.Kondo,
and
J.L.Strominger
(2008).
Positioning of autoimmune TCR-Ob.2F3 and TCR-Ob.3D1 on the MBP85-99/HLA-DR2 complex.
|
| |
Proc Natl Acad Sci U S A,
105,
15523-15528.
|
 |
|
|
|
|
 |
C.Mazza,
and
B.Malissen
(2007).
What guides MHC-restricted TCR recognition?
|
| |
Semin Immunol,
19,
225-235.
|
 |
|
|
|
|
 |
C.Mazza,
N.Auphan-Anezin,
C.Gregoire,
A.Guimezanes,
C.Kellenberger,
A.Roussel,
A.Kearney,
P.A.van der Merwe,
A.M.Schmitt-Verhulst,
and
B.Malissen
(2007).
How much can a T-cell antigen receptor adapt to structurally distinct antigenic peptides?
|
| |
EMBO J,
26,
1972-1983.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Feng,
C.J.Bond,
L.K.Ely,
J.Maynard,
and
K.C.Garcia
(2007).
Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction 'codon'.
|
| |
Nat Immunol,
8,
975-983.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.J.Sundberg,
L.Deng,
and
R.A.Mariuzza
(2007).
TCR recognition of peptide/MHC class II complexes and superantigens.
|
| |
Semin Immunol,
19,
262-271.
|
 |
|
|
|
|
 |
G.Cai,
and
D.A.Hafler
(2007).
Multispecific responses by T cells expanded by endogenous self-peptide/MHC complexes.
|
| |
Eur J Immunol,
37,
602-612.
|
 |
|
|
|
|
 |
G.P.Bondinas,
A.K.Moustakas,
and
G.K.Papadopoulos
(2007).
The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function.
|
| |
Immunogenetics,
59,
539-553.
|
 |
|
|
|
|
 |
J.A.Maynard,
R.Myhre,
and
B.Roy
(2007).
Microarrays in infection and immunity.
|
| |
Curr Opin Chem Biol,
11,
306-315.
|
 |
|
|
|
|
 |
K.W.Wucherpfennig,
P.M.Allen,
F.Celada,
I.R.Cohen,
R.De Boer,
K.C.Garcia,
B.Goldstein,
R.Greenspan,
D.Hafler,
P.Hodgkin,
E.S.Huseby,
D.C.Krakauer,
D.Nemazee,
A.S.Perelson,
C.Pinilla,
R.K.Strong,
and
E.E.Sercarz
(2007).
Polyspecificity of T cell and B cell receptor recognition.
|
| |
Semin Immunol,
19,
216-224.
|
 |
|
|
|
|
 |
L.A.Colf,
A.J.Bankovich,
N.A.Hanick,
N.A.Bowerman,
L.L.Jones,
D.M.Kranz,
and
K.C.Garcia
(2007).
How a single T cell receptor recognizes both self and foreign MHC.
|
| |
Cell,
129,
135-146.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Deng,
and
R.A.Mariuzza
(2007).
Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors.
|
| |
Trends Biochem Sci,
32,
500-508.
|
 |
|
|
|
|
 |
L.Deng,
R.J.Langley,
P.H.Brown,
G.Xu,
L.Teng,
Q.Wang,
M.I.Gonzales,
G.G.Callender,
M.I.Nishimura,
S.L.Topalian,
and
R.A.Mariuzza
(2007).
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor.
|
| |
Nat Immunol,
8,
398-408.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.J.Felix,
and
P.M.Allen
(2007).
Specificity of T-cell alloreactivity.
|
| |
Nat Rev Immunol,
7,
942-953.
|
 |
|
|
|
|
 |
N.Kaushansky,
R.Hemo,
M.Eisenstein,
and
A.Ben-Nun
(2007).
OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.
|
| |
Eur J Immunol,
37,
2018-2031.
|
 |
|
|
|
|
 |
S.Glatigny,
M.A.Blaton,
J.Marin,
S.Mistou,
J.P.Briand,
G.Guichard,
C.Fournier,
and
G.Chiocchia
(2007).
Insights into spatial configuration of a galactosylated epitope required to trigger arthritogenic T-cell receptors specific for the sugar moiety.
|
| |
Arthritis Res Ther,
9,
R92.
|
 |
|
|
|
|
 |
E.Y.Jones,
L.Fugger,
J.L.Strominger,
and
C.Siebold
(2006).
MHC class II proteins and disease: a structural perspective.
|
| |
Nat Rev Immunol,
6,
271-282.
|
 |
|
|
|
|
 |
L.K.Ely,
T.Beddoe,
C.S.Clements,
J.M.Matthews,
A.W.Purcell,
L.Kjer-Nielsen,
J.McCluskey,
and
J.Rossjohn
(2006).
Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction.
|
| |
Proc Natl Acad Sci U S A,
103,
6641-6646.
|
 |
|
|
|
|
 |
L.L.Jones,
S.E.Brophy,
A.J.Bankovich,
L.A.Colf,
N.A.Hanick,
K.C.Garcia,
and
D.M.Kranz
(2006).
Engineering and characterization of a stabilized alpha1/alpha2 module of the class I major histocompatibility complex product Ld.
|
| |
J Biol Chem,
281,
25734-25744.
|
 |
|
|
|
|
 |
M.G.Rudolph,
R.L.Stanfield,
and
I.A.Wilson
(2006).
How TCRs bind MHCs, peptides, and coreceptors.
|
| |
Annu Rev Immunol,
24,
419-466.
|
 |
|
|
|
|
 |
M.Sospedra,
P.A.Muraro,
I.Stefanová,
Y.Zhao,
K.Chung,
Y.Li,
M.Giulianotti,
R.Simon,
R.Mariuzza,
C.Pinilla,
and
R.Martin
(2006).
Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.
|
| |
J Immunol,
176,
1951-1961.
|
 |
|
|
|
|
 |
M.Sospedra,
and
R.Martin
(2006).
When T cells recognize a pattern, they might cause trouble.
|
| |
Curr Opin Immunol,
18,
697-703.
|
 |
|
|
|
|
 |
S.J.Turner,
P.C.Doherty,
J.McCluskey,
and
J.Rossjohn
(2006).
Structural determinants of T-cell receptor bias in immunity.
|
| |
Nat Rev Immunol,
6,
883-894.
|
 |
|
|
|
|
 |
H.Li,
S.Van Vranken,
Y.Zhao,
Z.Li,
Y.Guo,
L.Eisele,
and
Y.Li
(2005).
Crystal structures of T cell receptor (beta) chains related to rheumatoid arthritis.
|
| |
Protein Sci,
14,
3025-3038.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.A.Wilson,
and
R.L.Stanfield
(2005).
MHC restriction: slip-sliding away.
|
| |
Nat Immunol,
6,
434-435.
|
 |
|
|
|
|
 |
K.C.Garcia,
and
E.J.Adams
(2005).
How the T cell receptor sees antigen--a structural view.
|
| |
Cell,
122,
333-336.
|
 |
|
|
|
|
 |
M.Hahn,
M.J.Nicholson,
J.Pyrdol,
and
K.W.Wucherpfennig
(2005).
Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.
|
| |
Nat Immunol,
6,
490-496.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Krogsgaard,
and
M.M.Davis
(2005).
How T cells 'see' antigen.
|
| |
Nat Immunol,
6,
239-245.
|
 |
|
|
|
|
 |
S.B.Lovitch,
and
E.R.Unanue
(2005).
Conformational isomers of a peptide-class II major histocompatibility complex.
|
| |
Immunol Rev,
207,
293-313.
|
 |
|
|
|
|
 |
Y.Li,
Y.Huang,
J.Lue,
J.A.Quandt,
R.Martin,
and
R.A.Mariuzza
(2005).
Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
|
| |
EMBO J,
24,
2968-2979.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |